Pharma & Healthcare
Global Newborn Screening for SMA and SCID Market Research Report 2025
- Mar 11, 25
- ID: 124358
- Pages: 60
- Figures: 68
- Views: 19
The global market for Newborn Screening for SMA and SCID was valued at US$ 165 million in the year 2024 and is projected to reach a revised size of US$ 351 million by 2031, growing at a CAGR of 11.5% during the forecast period.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID.
The Newborn Screening for SMA and SCID market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Newborn Screening for SMA and SCID market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Screening for SMA and SCID companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Segment by Type
Instruments
Kits
Software
Segment by Application
SCID Screening
SMA Screening
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.
Severe combined immunodeficiency (SCID) is a group of rare disorders caused by mutations in different genes involved in the development and function of infection-fighting immune cells. Infants with SCID appear healthy at birth but are highly susceptible to severe infections.
Spinal muscular atrophy (SMA) is a group of hereditary diseases that progressively destroys motor neurons—nerve cells in the brain stem and spinal cord that control essential skeletal muscle activity such as speaking, walking, breathing, and swallowing, leading to muscle weakness and atrophy.
Global key players providing newborn screening for SMA and SCID are Perkinelmer, Thermo Fisher, ImmunoIVD, and Labsystems Diagnostics. The top four companies together hold 90% of the market share, with the largest vendor being Perkinelmer with 60% of the market share. The global companies providing newborn SMA and SCID screening are mainly located in North America and Europe, with North America holding the largest market share with 60%. In terms of product categories, kits dominate the market with 60% market share, followed by instruments and software with 35% and 5% market share, respectively. In terms of applications, SCID screening holds a 65% market share, while SMA screening is 35%.
This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID.
The Newborn Screening for SMA and SCID market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Newborn Screening for SMA and SCID market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Screening for SMA and SCID companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics
Segment by Type
Instruments
Kits
Software
Segment by Application
SCID Screening
SMA Screening
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instruments
1.2.3 Kits
1.2.4 Software
1.3 Market by Application
1.3.1 Global Newborn Screening for SMA and SCID Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 SCID Screening
1.3.3 SMA Screening
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Screening for SMA and SCID Market Perspective (2020-2031)
2.2 Global Newborn Screening for SMA and SCID Growth Trends by Region
2.2.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Newborn Screening for SMA and SCID Historic Market Size by Region (2020-2025)
2.2.3 Newborn Screening for SMA and SCID Forecasted Market Size by Region (2026-2031)
2.3 Newborn Screening for SMA and SCID Market Dynamics
2.3.1 Newborn Screening for SMA and SCID Industry Trends
2.3.2 Newborn Screening for SMA and SCID Market Drivers
2.3.3 Newborn Screening for SMA and SCID Market Challenges
2.3.4 Newborn Screening for SMA and SCID Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Screening for SMA and SCID Players by Revenue
3.1.1 Global Top Newborn Screening for SMA and SCID Players by Revenue (2020-2025)
3.1.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2020-2025)
3.2 Global Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Newborn Screening for SMA and SCID Revenue
3.4 Global Newborn Screening for SMA and SCID Market Concentration Ratio
3.4.1 Global Newborn Screening for SMA and SCID Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Screening for SMA and SCID Revenue in 2024
3.5 Global Key Players of Newborn Screening for SMA and SCID Head office and Area Served
3.6 Global Key Players of Newborn Screening for SMA and SCID, Product and Application
3.7 Global Key Players of Newborn Screening for SMA and SCID, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Screening for SMA and SCID Breakdown Data by Type
4.1 Global Newborn Screening for SMA and SCID Historic Market Size by Type (2020-2025)
4.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2026-2031)
5 Newborn Screening for SMA and SCID Breakdown Data by Application
5.1 Global Newborn Screening for SMA and SCID Historic Market Size by Application (2020-2025)
5.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Newborn Screening for SMA and SCID Market Size (2020-2031)
6.2 North America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Newborn Screening for SMA and SCID Market Size by Country (2020-2025)
6.4 North America Newborn Screening for SMA and SCID Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Screening for SMA and SCID Market Size (2020-2031)
7.2 Europe Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Newborn Screening for SMA and SCID Market Size by Country (2020-2025)
7.4 Europe Newborn Screening for SMA and SCID Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Screening for SMA and SCID Market Size (2020-2031)
8.2 Asia-Pacific Newborn Screening for SMA and SCID Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2020-2025)
8.4 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Screening for SMA and SCID Market Size (2020-2031)
9.2 Latin America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Newborn Screening for SMA and SCID Market Size by Country (2020-2025)
9.4 Latin America Newborn Screening for SMA and SCID Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Screening for SMA and SCID Market Size (2020-2031)
10.2 Middle East & Africa Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2020-2025)
10.4 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perkinelmer
11.1.1 Perkinelmer Company Details
11.1.2 Perkinelmer Business Overview
11.1.3 Perkinelmer Newborn Screening for SMA and SCID Introduction
11.1.4 Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2020-2025)
11.1.5 Perkinelmer Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Newborn Screening for SMA and SCID Introduction
11.2.4 Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2020-2025)
11.2.5 Thermo Fisher Recent Development
11.3 ImmunoIVD
11.3.1 ImmunoIVD Company Details
11.3.2 ImmunoIVD Business Overview
11.3.3 ImmunoIVD Newborn Screening for SMA and SCID Introduction
11.3.4 ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2020-2025)
11.3.5 ImmunoIVD Recent Development
11.4 Labsystems Diagnostics
11.4.1 Labsystems Diagnostics Company Details
11.4.2 Labsystems Diagnostics Business Overview
11.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Introduction
11.4.4 Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2020-2025)
11.4.5 Labsystems Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instruments
1.2.3 Kits
1.2.4 Software
1.3 Market by Application
1.3.1 Global Newborn Screening for SMA and SCID Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 SCID Screening
1.3.3 SMA Screening
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Newborn Screening for SMA and SCID Market Perspective (2020-2031)
2.2 Global Newborn Screening for SMA and SCID Growth Trends by Region
2.2.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Newborn Screening for SMA and SCID Historic Market Size by Region (2020-2025)
2.2.3 Newborn Screening for SMA and SCID Forecasted Market Size by Region (2026-2031)
2.3 Newborn Screening for SMA and SCID Market Dynamics
2.3.1 Newborn Screening for SMA and SCID Industry Trends
2.3.2 Newborn Screening for SMA and SCID Market Drivers
2.3.3 Newborn Screening for SMA and SCID Market Challenges
2.3.4 Newborn Screening for SMA and SCID Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Newborn Screening for SMA and SCID Players by Revenue
3.1.1 Global Top Newborn Screening for SMA and SCID Players by Revenue (2020-2025)
3.1.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2020-2025)
3.2 Global Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Newborn Screening for SMA and SCID Revenue
3.4 Global Newborn Screening for SMA and SCID Market Concentration Ratio
3.4.1 Global Newborn Screening for SMA and SCID Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Newborn Screening for SMA and SCID Revenue in 2024
3.5 Global Key Players of Newborn Screening for SMA and SCID Head office and Area Served
3.6 Global Key Players of Newborn Screening for SMA and SCID, Product and Application
3.7 Global Key Players of Newborn Screening for SMA and SCID, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Newborn Screening for SMA and SCID Breakdown Data by Type
4.1 Global Newborn Screening for SMA and SCID Historic Market Size by Type (2020-2025)
4.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2026-2031)
5 Newborn Screening for SMA and SCID Breakdown Data by Application
5.1 Global Newborn Screening for SMA and SCID Historic Market Size by Application (2020-2025)
5.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Newborn Screening for SMA and SCID Market Size (2020-2031)
6.2 North America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Newborn Screening for SMA and SCID Market Size by Country (2020-2025)
6.4 North America Newborn Screening for SMA and SCID Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Newborn Screening for SMA and SCID Market Size (2020-2031)
7.2 Europe Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Newborn Screening for SMA and SCID Market Size by Country (2020-2025)
7.4 Europe Newborn Screening for SMA and SCID Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Newborn Screening for SMA and SCID Market Size (2020-2031)
8.2 Asia-Pacific Newborn Screening for SMA and SCID Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2020-2025)
8.4 Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Newborn Screening for SMA and SCID Market Size (2020-2031)
9.2 Latin America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Newborn Screening for SMA and SCID Market Size by Country (2020-2025)
9.4 Latin America Newborn Screening for SMA and SCID Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Newborn Screening for SMA and SCID Market Size (2020-2031)
10.2 Middle East & Africa Newborn Screening for SMA and SCID Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2020-2025)
10.4 Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Perkinelmer
11.1.1 Perkinelmer Company Details
11.1.2 Perkinelmer Business Overview
11.1.3 Perkinelmer Newborn Screening for SMA and SCID Introduction
11.1.4 Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2020-2025)
11.1.5 Perkinelmer Recent Development
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Details
11.2.2 Thermo Fisher Business Overview
11.2.3 Thermo Fisher Newborn Screening for SMA and SCID Introduction
11.2.4 Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2020-2025)
11.2.5 Thermo Fisher Recent Development
11.3 ImmunoIVD
11.3.1 ImmunoIVD Company Details
11.3.2 ImmunoIVD Business Overview
11.3.3 ImmunoIVD Newborn Screening for SMA and SCID Introduction
11.3.4 ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2020-2025)
11.3.5 ImmunoIVD Recent Development
11.4 Labsystems Diagnostics
11.4.1 Labsystems Diagnostics Company Details
11.4.2 Labsystems Diagnostics Business Overview
11.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Introduction
11.4.4 Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2020-2025)
11.4.5 Labsystems Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Instruments
Table 3. Key Players of Kits
Table 4. Key Players of Software
Table 5. Global Newborn Screening for SMA and SCID Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Newborn Screening for SMA and SCID Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Newborn Screening for SMA and SCID Market Share by Region (2020-2025)
Table 9. Global Newborn Screening for SMA and SCID Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Newborn Screening for SMA and SCID Market Share by Region (2026-2031)
Table 11. Newborn Screening for SMA and SCID Market Trends
Table 12. Newborn Screening for SMA and SCID Market Drivers
Table 13. Newborn Screening for SMA and SCID Market Challenges
Table 14. Newborn Screening for SMA and SCID Market Restraints
Table 15. Global Newborn Screening for SMA and SCID Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Newborn Screening for SMA and SCID Market Share by Players (2020-2025)
Table 17. Global Top Newborn Screening for SMA and SCID Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2024)
Table 18. Ranking of Global Top Newborn Screening for SMA and SCID Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Newborn Screening for SMA and SCID Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Newborn Screening for SMA and SCID, Headquarters and Area Served
Table 21. Global Key Players of Newborn Screening for SMA and SCID, Product and Application
Table 22. Global Key Players of Newborn Screening for SMA and SCID, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Newborn Screening for SMA and SCID Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2020-2025)
Table 26. Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2026-2031)
Table 28. Global Newborn Screening for SMA and SCID Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2020-2025)
Table 30. Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2026-2031)
Table 32. North America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Newborn Screening for SMA and SCID Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)
Table 47. Perkinelmer Company Details
Table 48. Perkinelmer Business Overview
Table 49. Perkinelmer Newborn Screening for SMA and SCID Product
Table 50. Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)
Table 51. Perkinelmer Recent Development
Table 52. Thermo Fisher Company Details
Table 53. Thermo Fisher Business Overview
Table 54. Thermo Fisher Newborn Screening for SMA and SCID Product
Table 55. Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)
Table 56. Thermo Fisher Recent Development
Table 57. ImmunoIVD Company Details
Table 58. ImmunoIVD Business Overview
Table 59. ImmunoIVD Newborn Screening for SMA and SCID Product
Table 60. ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)
Table 61. ImmunoIVD Recent Development
Table 62. Labsystems Diagnostics Company Details
Table 63. Labsystems Diagnostics Business Overview
Table 64. Labsystems Diagnostics Newborn Screening for SMA and SCID Product
Table 65. Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)
Table 66. Labsystems Diagnostics Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
Table 70. Authors List of This Report
List of Figures
Figure 1. Newborn Screening for SMA and SCID Picture
Figure 2. Global Newborn Screening for SMA and SCID Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Newborn Screening for SMA and SCID Market Share by Type: 2024 VS 2031
Figure 4. Instruments Features
Figure 5. Kits Features
Figure 6. Software Features
Figure 7. Global Newborn Screening for SMA and SCID Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Newborn Screening for SMA and SCID Market Share by Application: 2024 VS 2031
Figure 9. SCID Screening Case Studies
Figure 10. SMA Screening Case Studies
Figure 11. Newborn Screening for SMA and SCID Report Years Considered
Figure 12. Global Newborn Screening for SMA and SCID Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Newborn Screening for SMA and SCID Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Newborn Screening for SMA and SCID Market Share by Region: 2024 VS 2031
Figure 15. Global Newborn Screening for SMA and SCID Market Share by Players in 2024
Figure 16. Global Top Newborn Screening for SMA and SCID Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Newborn Screening for SMA and SCID Revenue in 2024
Figure 18. North America Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Newborn Screening for SMA and SCID Market Share by Country (2020-2031)
Figure 20. United States Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Newborn Screening for SMA and SCID Market Share by Country (2020-2031)
Figure 24. Germany Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Newborn Screening for SMA and SCID Market Share by Region (2020-2031)
Figure 32. China Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Newborn Screening for SMA and SCID Market Share by Country (2020-2031)
Figure 40. Mexico Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Newborn Screening for SMA and SCID Market Share by Country (2020-2031)
Figure 44. Turkey Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Perkinelmer Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)
Figure 48. Thermo Fisher Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)
Figure 49. ImmunoIVD Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)
Figure 50. Labsystems Diagnostics Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Table 1. Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Instruments
Table 3. Key Players of Kits
Table 4. Key Players of Software
Table 5. Global Newborn Screening for SMA and SCID Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Newborn Screening for SMA and SCID Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Newborn Screening for SMA and SCID Market Share by Region (2020-2025)
Table 9. Global Newborn Screening for SMA and SCID Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Newborn Screening for SMA and SCID Market Share by Region (2026-2031)
Table 11. Newborn Screening for SMA and SCID Market Trends
Table 12. Newborn Screening for SMA and SCID Market Drivers
Table 13. Newborn Screening for SMA and SCID Market Challenges
Table 14. Newborn Screening for SMA and SCID Market Restraints
Table 15. Global Newborn Screening for SMA and SCID Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Newborn Screening for SMA and SCID Market Share by Players (2020-2025)
Table 17. Global Top Newborn Screening for SMA and SCID Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2024)
Table 18. Ranking of Global Top Newborn Screening for SMA and SCID Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Newborn Screening for SMA and SCID Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Newborn Screening for SMA and SCID, Headquarters and Area Served
Table 21. Global Key Players of Newborn Screening for SMA and SCID, Product and Application
Table 22. Global Key Players of Newborn Screening for SMA and SCID, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Newborn Screening for SMA and SCID Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2020-2025)
Table 26. Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2026-2031)
Table 28. Global Newborn Screening for SMA and SCID Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2020-2025)
Table 30. Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2026-2031)
Table 32. North America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Newborn Screening for SMA and SCID Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Newborn Screening for SMA and SCID Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Newborn Screening for SMA and SCID Market Size by Country (2026-2031) & (US$ Million)
Table 47. Perkinelmer Company Details
Table 48. Perkinelmer Business Overview
Table 49. Perkinelmer Newborn Screening for SMA and SCID Product
Table 50. Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)
Table 51. Perkinelmer Recent Development
Table 52. Thermo Fisher Company Details
Table 53. Thermo Fisher Business Overview
Table 54. Thermo Fisher Newborn Screening for SMA and SCID Product
Table 55. Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)
Table 56. Thermo Fisher Recent Development
Table 57. ImmunoIVD Company Details
Table 58. ImmunoIVD Business Overview
Table 59. ImmunoIVD Newborn Screening for SMA and SCID Product
Table 60. ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)
Table 61. ImmunoIVD Recent Development
Table 62. Labsystems Diagnostics Company Details
Table 63. Labsystems Diagnostics Business Overview
Table 64. Labsystems Diagnostics Newborn Screening for SMA and SCID Product
Table 65. Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2020-2025) & (US$ Million)
Table 66. Labsystems Diagnostics Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
Table 70. Authors List of This Report
List of Figures
Figure 1. Newborn Screening for SMA and SCID Picture
Figure 2. Global Newborn Screening for SMA and SCID Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Newborn Screening for SMA and SCID Market Share by Type: 2024 VS 2031
Figure 4. Instruments Features
Figure 5. Kits Features
Figure 6. Software Features
Figure 7. Global Newborn Screening for SMA and SCID Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Newborn Screening for SMA and SCID Market Share by Application: 2024 VS 2031
Figure 9. SCID Screening Case Studies
Figure 10. SMA Screening Case Studies
Figure 11. Newborn Screening for SMA and SCID Report Years Considered
Figure 12. Global Newborn Screening for SMA and SCID Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Newborn Screening for SMA and SCID Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Newborn Screening for SMA and SCID Market Share by Region: 2024 VS 2031
Figure 15. Global Newborn Screening for SMA and SCID Market Share by Players in 2024
Figure 16. Global Top Newborn Screening for SMA and SCID Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Newborn Screening for SMA and SCID Revenue in 2024
Figure 18. North America Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Newborn Screening for SMA and SCID Market Share by Country (2020-2031)
Figure 20. United States Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Newborn Screening for SMA and SCID Market Share by Country (2020-2031)
Figure 24. Germany Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Newborn Screening for SMA and SCID Market Share by Region (2020-2031)
Figure 32. China Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Newborn Screening for SMA and SCID Market Share by Country (2020-2031)
Figure 40. Mexico Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Newborn Screening for SMA and SCID Market Share by Country (2020-2031)
Figure 44. Turkey Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Newborn Screening for SMA and SCID Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Perkinelmer Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)
Figure 48. Thermo Fisher Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)
Figure 49. ImmunoIVD Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)
Figure 50. Labsystems Diagnostics Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Outdoor Shed Market Research Report 2025
Sep 09, 25
Global Residential Outdoor Cabinet Market Research Report 2025
Sep 09, 25
Global Outdoor Storage Cabinet Market Research Report 2025
Sep 09, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232